Omeros Corporation
OMER
#6443
Rank
$0.76 B
Marketcap
$10.85
Share price
-1.63%
Change (1 day)
-6.55%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2025 (TTM): -$0.13 Billion USD

According to Omeros Corporation's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -$0.16 Billion USD a decrease over its 2023 earnings that were of -$0.15 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$0.13 Billion-20.1%
2024 -$0.16 Billion9.63%
2023 -$0.15 Billion-9.57%
2022 -$0.16 Billion-30.65%
2021 -$0.23 Billion86.28%
2020 -$0.13 Billion99.45%
2019 -$61.83 Million-49.91%
2018 -$0.13 Billion190.77%
2017 -$42.46 Million-27.96%
2016 -$58.93 Million-17.61%
2015 -$71.53 Million1.88%
2014 -$70.21 Million87.56%
2013 -$37.43 Million
2011 -$27.41 Million-8.96%
2010 -$30.11 Million45.03%
2009 -$20.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eterna Therapeutics
ERNA
-$9.49 Million-92.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-$3.87 Million-96.94%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Pfizer
PFE
$11.85 B-9,490.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$32.39 B-25,768.33%๐Ÿ‡บ๐Ÿ‡ธ USA